Parkinson's Disease Progression Study

Active, not recruitingOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

February 20, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Parkinson Disease
Trial Locations (10)

30912

Augusta University Health Movement Disorder Clinic, Augusta

32720

Accel Research Sites DeLand, DeLand

32825

N1 Research LLC, Orlando

33486

Parkinsons Disease And Movement Disorders Center Of Boca Raton, Boca Raton

33777

Accel Research Sites St Petersburg-Largo, Largo

48334

Quest Research Institute, Farmington Hills

66160

University of Kansas Medical Center Parkinson's Disease and Movement Disorder Center, Kansas City

80045

University of Colorado Health Neurosciences Center, Aurora

89106

Cleveland Clinic, Las Vegas

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Koneksa Health

INDUSTRY

NCT06219629 - Parkinson's Disease Progression Study | Biotech Hunter | Biotech Hunter